Detalhe da pesquisa
1.
Recent advances in CAR-T cell therapy for acute myeloid leukaemia.
J Cell Mol Med
; 28(9): e18369, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712978
2.
ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming.
Acta Pharmacol Sin
; 44(11): 2282-2295, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37280363
3.
A selenosemicarbazone complex with copper efficiently down-regulates the 90-kDa heat shock protein HSP90AA1 and its client proteins in cancer cells.
BMC Cancer
; 14: 629, 2014 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25167922
4.
Biosensor based on ultrasmall MoS2 nanoparticles for electrochemical detection of H2O2 released by cells at the nanomolar level.
Anal Chem
; 85(21): 10289-95, 2013 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24067077
5.
T-ALL Cells as Tool Cells for CAR T Therapy.
Vaccines (Basel)
; 11(4)2023 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37112766
6.
CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities.
Vaccines (Basel)
; 11(1)2023 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36680011
7.
Nanoalbumin-prodrug conjugates prepared via a thiolation-and-conjugation method improve cancer chemotherapy and immune checkpoint blockade therapy by promoting CD8+ T-cell infiltration.
Bioeng Transl Med
; 8(1): e10377, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36684090
8.
Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL.
J Hematol Oncol
; 16(1): 113, 2023 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993905
9.
JUN mediates glucocorticoid resistance by stabilizing HIF1a in T cell acute lymphoblastic leukemia.
iScience
; 26(11): 108242, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38026210
10.
Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment.
Cell Metab
; 35(6): 961-978.e10, 2023 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178684
11.
The heme oxygenase-1 inhibitor ZnPPIX induces non-canonical, Beclin 1-independent, autophagy through p38 MAPK pathway.
Acta Biochim Biophys Sin (Shanghai)
; 44(10): 815-22, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875631
12.
Establishment of a New Cryopreservation Solution for Chimeric Antigen Receptor T Cells.
Biopreserv Biobank
; 20(6): 567-574, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294840
13.
Dynamic Expression of EpCAM in Primary and Metastatic Lung Cancer Is Controlled by Both Genetic and Epigenetic Mechanisms.
Cancers (Basel)
; 14(17)2022 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077658
14.
Computational characterization of domain-segregated 3D chromatin structure and segmented DNA methylation status in carcinogenesis.
Mol Oncol
; 16(3): 699-716, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34708506
15.
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma.
Exp Hematol Oncol
; 11(1): 72, 2022 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36253833
16.
Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT.
Signal Transduct Target Ther
; 7(1): 101, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35399106
17.
Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia.
Blood Sci
; 4(1): 16-28, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35399540
18.
B cell deficiency promotes the initiation and progression of lung cancer.
Front Oncol
; 12: 1006477, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36249034
19.
The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity.
Sci Rep
; 12(1): 10488, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35729339
20.
3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
Nat Commun
; 12(1): 3708, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140506